Everolimus-13C2,d4, CAS [[1661009-29-5]] Preis auf Anfrage

Artikelnummer: MCE-HY-10218S1
Artikelname: Everolimus-13C2,d4, CAS [[1661009-29-5]] Preis auf Anfrage
Artikelnummer: MCE-HY-10218S1
Hersteller Artikelnummer: HY-10218S1
Alternativnummer: MCE-HY-10218S1-1UNIT
Hersteller: MedchemExpress
Kategorie: Biochemikalien
Alternative Synonym: RAD001-13C2,d4, SDZ-RAD-13C2,d4
Everolimus-13C2,d4 (RAD001-13C2,d4) is 13C labeled Everolimus. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2].
Molekulargewicht: 964.23
CAS Nummer: [1661009-29-5]
Formel: C51 13C2H79D4NO14
Target-Kategorie: Apoptosis,Autophagy,Bacterial,FKBP,Isotope-Labeled Compounds,mTOR
Anwendungsbeschreibung: MCE Product type: Isotope-Labeled Compounds